EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Urolithin A Modulates SIRT ‐1 Mediated Improvement of Mitochondrial Health in Experimental Model of Oxaliplatin Induced Peripheral Neuropathy

Anubroto Pal iD, Sayani Banerjee, Lokesh Sharan, Ravindra Kumar, Neelanjan Chowdhury iD, Arka Das, S Sarath Babu iD, David Paul iD, Sugato Banerjee iD

Phytotherapy Research · 13.11.2026

DOI: 10.1002/ptr.70506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 13.11.2026. Verfasst von Anubroto Pal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Kolkata, India. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Pharmaceutical Education and Research, Kolkata.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxaliplatin‐induced peripheral neuropathy (OIPN) is a major dose‐limiting adverse reaction of chemotherapy. It is characterised by motor and sensory hypersensitivity, loss of myelinated nerve fibres, oxidative stress, mitochondrial dysfunction and neuroinflammation. Urolithin A, a bioactive gut metabolite of ellagitannins, is recognised for its ability to restore mitochondrial homeostasis. This study investigated the neuroprotective efficacy of urolithin A against experimental OIPN, focusing on its ability to simultaneously balance mitochondrial biogenesis and mitophagy. To study OIPN, male Sprague–Dawley rats were administered oxaliplatin (4 mg/kg) over a 4‐week period, paired with concurrent oral doses of urolithin A (25 and 50 mg/kg). The animals were evaluated through behavioural assays (Von Frey, Hargreaves Plantar and Randall‐Selitto, etc.) and functional tests measuring sensory and motor nerve conduction velocity. Oxidative stress markers (MDA and GSH) and mitochondrial dynamics, specifically biogenesis and mitophagy, were measured. In parallel, an in vitro study exposed Neuro2a cells to 50 μM of oxaliplatin, followed by urolithin A treatment (15 μM), to investigate its neuroprotective efficacy and underlying molecular mechanisms. Urolithin A significantly attenuated OIPN, alleviating thermal and mechanical hypersensitivity in behavioural assessments. It mitigated oxidative stress and mitochondrial dysfunction while promoting mitochondrial biogenesis via the SIRT1‐mediated pathway both in vitro and in vivo. Simultaneously, urolithin A enhanced mitophagy by directly activating SIRT1‐induced autophagy markers, leading to a marked reduction in inflammatory cytokine levels and eventual mitigation of neuropathic pain. Urolithin A protected against oxaliplatin‐induced neurotoxicity in Neuro2a cells and reversed peripheral neuropathy in rats by restoring SIRT1‐mediated mitochondrial biogenesis and mitophagy balance and maintaining mitochondrial health. These findings highlight urolithin A as a potential therapeutic candidate for OIPN.

Schlagwörter

Stichwörter der Autor:innen

inflammationmitochondrial biogenesismitophagyoxaliplatinoxidative stressperipheral neuropathy

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Kolkata, India.
  • Department of Natural Products, National Institute of Pharmaceutical Education and Research, Kolkata, India.
  • Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Kolkata, India.
  • Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Kolkata, India.

ORCID-Profile: Anubroto Pal, Neelanjan Chowdhury, S Sarath Babu, David Paul, Sugato Banerjee

Förderung

  • National Institute of Pharmaceutical Education and Research, Kolkata

Zitieren

APA

Pal, A., Banerjee, S., Sharan, L., Kumar, R., Chowdhury, N., Das, A., Babu, S. S., Paul, D., & Banerjee, S. (2026). Urolithin A Modulates SIRT ‐1 Mediated Improvement of Mitochondrial Health in Experimental Model of Oxaliplatin Induced Peripheral Neuropathy. Phytotherapy Research. https://doi.org/10.1002/ptr.70506

Vancouver

Pal A, Banerjee S, Sharan L, Kumar R, Chowdhury N, Das A, et al. Urolithin A Modulates SIRT ‐1 Mediated Improvement of Mitochondrial Health in Experimental Model of Oxaliplatin Induced Peripheral Neuropathy. Phytotherapy Research. 2026. doi:10.1002/ptr.70506

BibTeX
@article{Pal2026,
  author = {Pal, Anubroto and Banerjee, Sayani and Sharan, Lokesh and Kumar, Ravindra and Chowdhury, Neelanjan and Das, Arka and Babu, S Sarath and Paul, David and Banerjee, Sugato},
  title = {Urolithin A Modulates SIRT ‐1 Mediated Improvement of Mitochondrial Health in Experimental Model of Oxaliplatin Induced Peripheral Neuropathy},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70506}
}
Kostenlos starten →